Logo image
Effects of diagnosed dementia on Medicare and Medicaid program costs
Journal article   Peer reviewed

Effects of diagnosed dementia on Medicare and Medicaid program costs

Padmaja Ayyagari, Martin Salm and Frank A Sloan
Inquiry (Chicago), Vol.44(4), pp.481-494
2007
DOI: 10.5034/inquiryjrnl_44.4.481
PMID: 18338520
url
https://doaj.org/article/f1dfafa81477460084507111c8fe7fc7View
Open Access

Abstract

This study examines the impacts of physician-diagnosed Alzheimer's disease and related dementias (ADRD) on Medicare and Medicaid program costs in 1994 and 1999. An innovative method is employed to estimate program payments over the life cycle starting at age 65. Using data from the 1994 and 1999 National Long-Term Care Surveys, merged Medicare claims, and national program data for Medicaid, we find that the share of total Medicare and Medicaid payments attributable to diagnosed ADRD was 5.46% in 1999. Total annual program payments attributable to ADRD decreased between 1994 and 1999, in contrast to an increase implied by a cross-sectional approach.
Activities of Daily Living Aged Dementia - diagnosis Dementia - economics Dementia - mortality Female Health Services - utilization Homes for the Aged - economics Humans Insurance Claim Review Male Medicaid - economics Medicare - economics Models, Econometric Nursing Homes - economics United States

Details

Logo image